Antony Mattessich

Antony Mattessich has a diverse range of work experience in the pharmaceutical industry. Antony began their career at Bristol-Myers Squibb, where they held various management positions including General Manager of Malaysia, Singapore, and Brunei, Managing Director of The Netherlands, VP of Virology Marketing, and VP of Operations. Antony then moved on to Novartis, where they served as VP of Respiratory and Dermatology. Following this, Mattessich joined Napp Pharmaceuticals as Managing Director before later joining Mundipharma as Head of Western Europe and eventually became the Managing Director of Mundipharma International. Currently, Mattessich serves as the President and CEO of Ocular Therapeutix, Inc.

Antony Mattessich pursued their education in a systematic and focused manner. Antony first attended the University of California, Berkeley, from 1986 to 1990, where they obtained a Bachelor of Arts degree. Their primary field of study during this period was Religious Violence/Terrorism.

After completing their undergraduate studies, Antony proceeded to Columbia | SIPA, where they enrolled in the Master of International Affairs (MIA) program. Antony dedicated himself to this program from 1991 to 1993, during which they focused on International Policy Analysis and Management.

These educational experiences at both institutions provided Antony Mattessich with a solid foundation of knowledge pertaining to their areas of interest.